Physician profile
Byron Tyrell Mathis
NPI 1578038337
$2,406.42
in general payments reported to CMS, 2019-2025
15 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $308 · 2023: $354 · 2024: $1,137 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952 · Travel and Lodging: $936 · Education: $99.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.24 |
| Travel and Lodging | $935.57 |
| Education | $99.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,310.21 | 2022-2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $259.93 | 2021-2024 | Dupixent |
| Optinose US, INC. | $246.13 | 2021-2024 | |
| Dexcom, INC. | $188.56 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Boston Scientific Corporation | $138.08 | 2025 | Watchman Flx |
| Abbvie INC. | $54.12 | 2025 | |
| Genzyme Corporation | $36.18 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $35.71 | 2025 | Farxiga |
| Otsuka America Pharmaceutical, INC. | $30.63 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $29.10 | 2021-2022 | |
| Exact Sciences Corporation | $17.48 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $16.79 | 2025 | Mounjaro, Zepbound |
| Kaleo, INC. | $15.01 | 2021 | |
| Supernus Pharmaceuticals, INC. | $14.85 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $13.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.